Skip to main content

Pfizer Inc(PFE-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Purpose Life Sciences Creates Strategic Advisory Board, Appoints Jeffrey B. Kindler and Calum MacRae, MD, PhD, to Further Efforts in Revolutionizing Global Clinical Trial Research

Newswire.ca - Tue Sep 19, 8:00AM CDT

Former Pfizer CEO, PPD Board Member and top Harvard cardiology researcher augment the company's expertise and global research connections

VANCOUVER, BC, Sept. 19, 2023 /CNW/ - Purpose Life Sciences (PLS) today announced the appointment of Jeff Kindler and Calum MacRae, MD, PhD to the company's newly created Strategic Advisory Board (SAB) to help advance its mission in innovating clinical trial research and accelerating access to life saving medications in the communities that need them most.

Read more at newswire.ca

Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2023.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).